According to a recent study, patients with comorbid psoriatic arthritis (PsA) have a slightly decreased treatment response to biologics for psoriasis (PsO) than those without PsA.
According to a recent study, patients with comorbid psoriatic arthritis (PsA) have a slightly decreased treatment response to biologics for psoriasis (PsO) than those without PsA.